BioNet-Asia has allegedly fallen victim to The Gentlemen ransomware group, which infiltrated their network using advanced evasion techniques to steal sensitive data before encryption. This incident highlights the growing threat of sophisticated cyberattacks targeting healthcare and biotechnology sectors. #TheGentlemen #BioNetAsia #Ransomware #Cyberattack #HealthcareSecurity
Keypoints
- The Gentlem en ransomware group compromised BioNet-Asia, a vaccine manufacturer in Thailand.
- The threat actors used techniques such as disabling security software and manipulating Group Policy Objects.
- Sensitive data exfiltrated includes personal, financial, and proprietary vaccine research information.
- The attack occurred in 2025, showing an expansion of the group’s operational scope.
- BioNet is known for developing recombinant and mRNA vaccines targeting respiratory diseases in Southeast Asia.
Read More: https://dailydarkweb.net/bionet-asia-targeted-in-gentlemen-ransomware-attack/